Gene · 6947
NIH grants1,067
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 1,067
Download this page as JSON| Grant | Title | TCN1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI136581 | Lentivirus Replication Strategy and Pathogenesis | 2 | 2025 |
| R01AR040312 | CD1-restricted T-cell Responses in Skin | 2 | 2025 |
| R01HL049277 | Animal Models for Studying the Genetics of Complex Diseases | 2 | 2025 |
| R35GM122550 | Genomic and Physiological Impact of Transposable Elements. | 2 | 2025 |
| T32AI055434 | Training Program in Microbial Pathogenesis | 2 | 2025 |
| T32CA082084 | Cancer Immunology Training Program | 2 | 2025 |
| UM1AI068634 | Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | 2 | 2025 |
| UM1AI068636 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2 | 2025 |
| ZIADK036153 | Structure and function of eukaryotic DNA transposases | 2 | 2025 |
| ZIAHD002400 | The Role Of Subclinical Infection And Cytokines In Preterm Parturition | 2 | 2025 |
| DP2AI164325 | Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious disease | 1 | 2025 |
| F31CA290756 | Role of physical exercise-induced microbiota changes in immunotherapy resistant preclinical melanoma | 1 | 2025 |
| F32CA284780 | Metabolic control of tRNA-mediated translational reprogramming in glioblastoma | 1 | 2025 |
| I01BX004258 | Genome engineering therapeutics for cystinuria and its metabolic consequences. | 1 | 2025 |
| K01DK125614 | Role of GPR56 in glomerular endothelial cell injury in early diabetic kidney disease | 1 | 2025 |
| K01DK133620 | Engineered Hydrogel Elucidates the Contribution of ECM Stiffness to Barrett's Esophagus Pathogenesis | 1 | 2025 |
| K08DK128631 | A generic and immunological investigation of JAK-STAT in the pathogenesis of Celiac | 1 | 2025 |
| K12CA086913 | Paul Calabresi Award in Clinical Oncology Research | 1 | 2025 |
| K12GM111725 | IRACDA at the University of Michigan | 1 | 2025 |
| K12HD087023 | Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6947/grants?page=2